Thu, January 9, 2020
Wed, January 8, 2020
Tue, January 7, 2020
Mon, January 6, 2020
Fri, January 3, 2020
Thu, January 2, 2020
Tue, December 31, 2019
Mon, December 30, 2019
Fri, December 27, 2019
Thu, December 26, 2019
Tue, December 24, 2019
Mon, December 23, 2019
Fri, December 20, 2019
Thu, December 19, 2019

Edward Tenthoff Maintained (VRTX) at Buy with Increased Target to $284 on, Jan 6th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-284-on-jan-6th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Edward Tenthoff of Piper Sandler, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $247 to $284 on, Jan 6th, 2020.

Edward has made no other calls on VRTX in the last 4 months.



There are 5 other peers that have a rating on VRTX. Out of the 5 peers that are also analyzing VRTX, 0 agree with Edward's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Edward


  • Ying Huang of "B of A Securities" Reiterated at Strong Buy with Increased Target to $245 on, Wednesday, November 20th, 2019
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $229 on, Tuesday, November 19th, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $250 on, Thursday, October 31st, 2019
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $229 on, Thursday, October 31st, 2019
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $225 on, Tuesday, October 22nd, 2019

Publication Contributing Sources